MacroGenics Inc. Stock
Price
Target price
€3.84
€3.84
2.560%
0.102
2.560%
€12.42
29.05.24 / Tradegate
WKN: A1W6ND / Symbol: MGNX / Name: MacroGenics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
MacroGenics Inc. Stock
There is an upward development for MacroGenics Inc. compared to yesterday, with an increase of €0.10 (2.560%).
With 13 Buy predictions and not the single Sell prediction the community is currently very high on MacroGenics Inc..
With a target price of 12 € there is potential for a 212.66% increase which would mean more than doubling the current price of 3.84 € for MacroGenics Inc..
Our community identified positive and negative aspects for MacroGenics Inc. stock for the coming years. 5 users see the criterium "Worthwhile Investment for the next years" as a plus for the MacroGenics Inc. stock. On the other hand our users think that "Valuation (undervalued/overvalued)" could be a problem in the future.
Pros and Cons of MacroGenics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MacroGenics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| MacroGenics Inc. | 2.560% | -8.706% | -72.229% | -12.374% | -57.356% | -84.605% | - |
| Ardelyx Inc. | 3.070% | 1.608% | 5.441% | 102.500% | 9.308% | 7.085% | - |
| Evolus Inc | - | 0.000% | 7.477% | 37.725% | 27.072% | 32.948% | - |
| Salarius Pharmaceuticals Inc. | - | -3.015% | -6.311% | -66.724% | -30.450% | -98.501% | -99.994% |
Comments
MacroGenics, Inc. (NASDAQ: MGNX) had its price target lowered by analysts at BTIG Research from $24.00 to $9.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MGNX provided by MarketBeat
MacroGenics, Inc. (NASDAQ: MGNX) had its price target lowered by analysts at Barclays PLC from $25.00 to $14.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MGNX provided by MarketBeat
MacroGenics, Inc. (NASDAQ: MGNX) is now covered by analysts at B. Riley. They set a "buy" rating and a $25.00 price target on the stock.
Show more
Ratings data for MGNX provided by MarketBeat
News
MacroGenics (MGNX) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
MacroGenics (NASDAQ: MGNX)Q1 2024 Earnings CallMay 09, 2024, 4:30 p.m. ET
Operator
Source Fool.com
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
MacroGenics (NASDAQ: MGNX)Q4 2023 Earnings CallMar 07, 2024, 4:30 p.m. ET
Operator
Source Fool.com